Global Registry of Acute Coronary Events (GRACE) study
Jump to navigation
Jump to search
Introduction
,Global Registry of Acute Coronary Events (GRACE)
Study characteristics:
- Cohort study
- 94 hospitals in 14 countries
- 19,537 patients presenting with acute coronary syndrome
- April 1999 to September 2002
Groups:
- Statin use before presentation (1a)
- Statin use discontinued upon hospital admission (1b)
- Statin started after presentation (2)
- No statin use (3)
End points:
- death, in-hospital myocardial infarction, & stroke
Results:
- patients in group 1 were less likely to have
- ST-segment elevation (odds ratio 0.79)
- myocardial infarction (OR 0.78)
- patients in group 1a were less likely to experience complications or die than patients in group 3 (OR 0.66)
- patients in group 2 were less likely to die than patients in group 3 (OR 0.38)
- adjustment for the hospital of admission attenuated the association between initiation of statin therapy & the composite end point (OR 0.84)
More general terms
References
- ↑ Journal Watch 24(14):110, 2004 a) Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KA, Granger CB, Mehta RH, Brieger D; GRACE Investigators. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med. 2004 Jun 1;140(11):857-66. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15172899 b) Laupacis A, Mamdani M. (editorial) Observational studies of treatment effectiveness: some cautions. Ann Intern Med. 2004 Jun 1;140(11):923-4. No abstract available. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15172907